Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Francisco Santos Gonzalez

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Applied Health Economics and Health Policy|July 9, 2024
How is Value Defined in Molecular Testing in Cancer? A Scoping ReviewAlice Minhinnick, Francisco Santos-Gonzalez, Michelle Wilson, et al.
BMJ Open|November 29, 2023
Development of a microcosting protocol to determine the economic cost of diagnostic genomic testing for rare diseases in AustraliaDylan A Mordaunt, Zornitza Stark, Francisco Santos Gonzalez, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|March 20, 2023
Microcosting diagnostic genomic sequencing: A systematic reviewFrancisco Santos Gonzalez, Dylan Mordaunt, Zornitza Stark, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|November 10, 2024
Microcosting genomics: Challenges and opportunitiesFrancisco Santos Gonzalez, Wendy J Ungar, James Buchanan, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|December 16, 2025
The value of functional genomics: a contingent valuationFrancisco Santos Gonzalez, Ellenore Martin, Madeleine Harris, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|January 2, 2024
The cost of proband and trio exome and genome analysis in rare disease: A micro-costing studyDylan A Mordaunt, Francisco Santos Gonzalez, Sebastian Lunke, et al.
Orphanet Journal of Rare Diseases|November 29, 2024
A micro-costing study of mass-spectrometry based quantitative proteomics testing applied to the diagnostic pipeline of mitochondrial and other rare disordersFrancisco Santos Gonzalez, Daniella H Hock, David R Thorburn, et al.
Applied Health Economics and Health Policy|April 2, 2025
The Cost Effectiveness of Genomic Medicine in Cancer Control: A Systematic Literature ReviewMackenzie Bourke, Aideen McInerney-Leo, Julia Steinberg, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Applied Health Economics and Health Policy|July 9, 2024
How is Value Defined in Molecular Testing in Cancer? A Scoping ReviewAlice Minhinnick, Francisco Santos-Gonzalez, Michelle Wilson, et al.
BMJ Open|November 29, 2023
Development of a microcosting protocol to determine the economic cost of diagnostic genomic testing for rare diseases in AustraliaDylan A Mordaunt, Zornitza Stark, Francisco Santos Gonzalez, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|March 20, 2023
Microcosting diagnostic genomic sequencing: A systematic reviewFrancisco Santos Gonzalez, Dylan Mordaunt, Zornitza Stark, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|November 10, 2024
Microcosting genomics: Challenges and opportunitiesFrancisco Santos Gonzalez, Wendy J Ungar, James Buchanan, et al.
Expert Review of Pharmacoeconomics & Outcomes Research|December 16, 2025
The value of functional genomics: a contingent valuationFrancisco Santos Gonzalez, Ellenore Martin, Madeleine Harris, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|January 2, 2024
The cost of proband and trio exome and genome analysis in rare disease: A micro-costing studyDylan A Mordaunt, Francisco Santos Gonzalez, Sebastian Lunke, et al.
Orphanet Journal of Rare Diseases|November 29, 2024
A micro-costing study of mass-spectrometry based quantitative proteomics testing applied to the diagnostic pipeline of mitochondrial and other rare disordersFrancisco Santos Gonzalez, Daniella H Hock, David R Thorburn, et al.
Applied Health Economics and Health Policy|April 2, 2025
The Cost Effectiveness of Genomic Medicine in Cancer Control: A Systematic Literature ReviewMackenzie Bourke, Aideen McInerney-Leo, Julia Steinberg, et al.
Pageof 1